AG10
AG10-201
Phase 2 small_molecule completed
Quick answer
AG10 for Familial ATTR-CM (ATTRm-CM, or FAC) is a Phase 2 program (small_molecule) at BridgeBio Oncology Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BridgeBio Oncology Therapeutics
- Indication
- Familial ATTR-CM (ATTRm-CM, or FAC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed